SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-059165
Filing Date
2023-12-22
Accepted
2023-12-22 16:21:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 DFAN14A ef20017313_dfan14a.htm DFAN14A 31980
2 JOINT PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY AND KARUNA THERAPEUTICS, INC ef20017313_ex99-1.htm EX-99.1 35407
  Complete submission text file 0001140361-23-059165.txt   69106
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Subject) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-38958 | Film No.: 231510105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)